tirzepatide and kidney damage Renal effects of GLP-1 receptor agonists in individuals with type 2 diabetes: seeds of a promising future | Endocrine Protecting kidneys is a crucial

These medications are not FDA-approved, but they allow providers to tailor the dosage specifically to your needs during a transition

Make it count

This information provides valuable insight into energy balance and can reveal patterns that may explain weight changes

B.BobakY.DAmicoD

The contract is where we would slow down

When muscle mass drops too much: Your metabolism slows down , so you burn fewer calories You lose strength, stability, and energy You may regain fat more easily after stopping the medication You increase your risk of long-term frailty and poor body composition The goal isnt just to lose weight its to lose fat while keeping (or gaining) strength